Paris-based private equity firm, Archimed, has initiated the delisting from Korea Exchange of shares in Jeisys Medical, a leading developer of aesthetic medicine devices, after acquiring Jeisys Medical via change-of-control…
Korea: Archimed takes Jeisys private to support non-invasive aesthetic international growth
…
…






